THC Therapeutics, Inc.
$0.00$0.00 (0.0%)
THC Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.3% below the high.
OTC · CYPS · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Cyclo3pss Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Cyclo3pss Corporation operated primarily in the ozone technology sector. Its business encompassed the licensing, manufacturing, sales, and installation of ozone-based products for food processing, as well as providing ozone washing, sorting, and counting systems for commercial and institutional laundries. Additionally, the firm was involved in the research and development of sterilization and disinfection technologies for various consumer goods. Established in Salt Lake City, Utah, the company traced its origins back to 1927. However, in July 2002, Cyclo3pss's Board of Directors made the decision to immediately cease all company operations. This drastic step was taken due to an inability to attract willing investors and secure the essential financing required for continued business.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00$0.00 (0.0%)
THC Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.3% below the high.
$0.00$0.00 (0.0%)
Net Medical Xpress Solutions, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.14% below the high.
$0.00$0.00 (0.0%)
Remedent, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
UpHealth, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.0% below the high.
$0.00$0.00 (0.0%)
Kaleido Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.95% below the high.
$0.00$0.00 (0.0%)
Emergent Health Corp’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
Nemaura Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Ventura Cannabis & Wellness Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.